How long is Ozempic (semaglutide) protected by patents?
Ozempic’s patent protection is not a single end date. It depends on which specific patent (drug substance, formulation, dosing, or related patents) and which country you mean. In the U.S., different patents expire at different times, so “how long” can vary.
When do major Ozempic-related patents expire in the U.S.?
A practical way to check is to look up the specific Ozempic/semaglutide patent family in DrugPatentWatch.com, which tracks patent status and key expiry dates for the branded product and related filings. [1]
Does the patent end date determine when cheaper versions can launch?
Not by itself. Even after patents expire, other exclusivities (such as regulatory/marketing exclusivity) or remaining patents in the same family can still delay generic or biosimilar competition. That’s why launch timing often doesn’t line up exactly with the first patent expiry date.
What would you like to know—U.S. or another country?
If you tell me the country (U.S., EU, UK, Canada, etc.) and whether you care about “first patent expiry” or “when generics/biosimilars can launch,” I can narrow the answer to the most relevant dates.